Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @GeneOnlineNews
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @GeneOnlineNews
-
Seqirus’ AUDENZTM, a vaccine for a potential pandemic associated with the H5N1 flu virus commonly known as “bird flu” was approved by the
@US_FDA on Monday.#BirdFlu#Influenza#vaccinehttps://wp.me/pb0TAP-11wHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
February 4th, observed as the World Cancer Day aims to raise global awareness about prevention, detection, and treatment of cancer. This year's theme is "I Am and I Will" and puts the focus on our commitment to act.
#UICC#Cancer#CancerDay2020https://wp.me/pb0TAP-11sHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Here's an interesting read from
@nature "Step aside CRISPR, RNA editing is taking off"https://www.nature.com/articles/d41586-020-00272-5 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#WeeklyinAsia 0127-0202 1. Companies Developing#2019nCoV Vaccine 2.#Gilead Tests Ebola Drug as New Coronavirus Treatment 3.#Eisai Commences Joint Research and Development of Cancer Gene Panel Test with Personal Genome Diagnostics#GeneOnlinehttps://wp.me/pb0TAP-11lHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New Jersey based biopharma,
@Insmed Incorporated today reported positive Phase II results for INS1007, a potential#drug for treating non-cystic fibrosis#bronchiectasis (NCFBE). The company’s stocks skyrocketed 36% upon release of the news.#clinicaltrialhttps://wp.me/pb0TAP-11iHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
@US_FDA has issued 6 new guidances to enhance the development of new gene therapy products. The policies are drafted to regulate the rapidly progressing field and preserve the agency's motto of supporting innovations.#genetherapy#guidancehttps://wp.me/pb0TAP-117Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Mammoth Biosciences (
@mammothbiosci), co-founded by#CRISPR gene-editing technology pioneer, Jennifer Doudna, has raised $45 million in#SeriesB funding. The company plans to funnel the funds into expanding in the direction of CRISPR based#therapeutics.https://wp.me/pb0TAP-10XHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Aimmune Therapeutics (
@aimmune) announce@US_FDA approval of its oral immunotherapy drug, PALFORZIA™ for the treatment of children between ages 4 and 17 who suffer from peanut allergy. With this, the drug became the first treatment for#peanutallergy.https://geneonline.news/en/2020/01/31/aimmunes-palforzia-scores-fda-win-becomes-the-first-ever-treatment-for-peanut-allergy/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The First
@sanofi designed investigational enzyme replacement therapy, Olipudase Alfa succeeds in Phase II/III trial that evaluated it for the treatment of Niemann-Pick Disease.#clinicaltrials#enzymereplacementhttps://geneonline.news/en/2020/01/31/first-sanofi-designed-investigational-enzyme-replacement-therapy-for-asmd-gets-green-signal-in-phase-ii-iii-trial/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The World Health Organization officially declares the novel coronavirus outbreak as a Public Health Emergency of International Concern (PHEIC) following a second meeting on January 30.
#CoronavirusOutbreak#WuhanCoronavirus#WorldHealthOrganizationhttps://geneonline.news/en/2020/01/30/who-declares-2019-ncov-outbreak-a-global-health-emergency/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Update on the 2019 novel Coronavirus (2019-nCov): The latest progress In vaccine development and treatment.
#coronavirus#CoronavirusOutbreak#Wuhan#vaccines#WorldHealthOrganisationhttps://geneonline.news/en/2020/01/30/update-on-2019-novel-coronavirus-2019-ncov-the-latest-progress-in-vaccine-development-and-treatment/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#AsiaMicrobiomeConference held in Taiwan at the beginning of 2020 is mainly hosted by#ToolsBiotechnology. Well-known experts& scholars from different parts of Asia gathered in Taiwan to share the latest trends& research in human microbiome.#GeneOnelinehttps://wp.me/pb0TAP-109Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A collaborative study led by researchers from the Technical University of Munich (TUM) has demonstrated the successful use of CRISPR-Cas9 to correct the defective dystrophin gene in a pig model of Duchenne Muscular Dystrophy.
#tumünchen#CRISPRhttps://geneonline.news/en/2020/01/28/scientists-use-crispr-to-fight-duchenne-muscular-dystrophy/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With the success in 2019, the BIO Asia-Taiwan International Conference and Exhibition, jointed by Taiwan Bio Industry Organization (Taiwan BIO) and the US-based Bio Innovation Organization (BIO) will be held AGAIN in 2020! Apply to exhibit NOW: http://bit.ly/38P21Hh pic.twitter.com/Fm0Q2GocIT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Nagendra Chemuturi of
@Novartis discussed duration of action, Biodistribution &other challenges of#Gene#therapies in his talk "Role of Modeling & Simulation in#Drug Development" organized by@BostonQsp. He stressed the importance of doing what's meaningful for the product.pic.twitter.com/QVV0lytvsx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
GeneOnline proslijedio/la je Tweet
News & Views: A study published in Nature identifies the mechanism governing premature greying in mice that have experienced stress.https://go.nature.com/3aCrS6W
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In another step towards fighting relapsed Diffuse Large B-Cell Lymphoma (DLBCL), a type of blood cancer,
@Roche scores EU approval for its novel combination therapy involving the antibody-drug conjugate, Polivy.#drugapproval#lymphoma https://geneonline.news/en/2020/01/24/polivy-a-new-and-improved-arsenal-from-roche-to-fight-dlbcl-relapse/ …pic.twitter.com/DIv0zZJauV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#WeeklyinAsia 0113-0119 1. LATEST Trends on Cell Therapy in Taiwan 2. 2019–20 outbreak of novel#coronavirus (#2019nCoV) 3.#CharlesRiver and#Takeda Partners to Identify and Develop Preclinical Candidates#GeneOnlinehttps://wp.me/pb0TAP-10dHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
On January 21st, Dublin based Horizon Therapeutics received the early
#FDA authorization of its human monoclonal antibody, Tepezza. With this, the drug became the first and only approved treatment for Thyroid Eye Disease (TED), a rare autoimmune disorder.https://geneonline.news/en/2020/01/22/fda-greenlights-tepezza-as-first-treatment-for-thyroid-eye-disease/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The intestinal flora, which was often forgotten in the past, was warmly discussed at the 4th Asia Microbiome Conference, which was held in Taiwan at the beginning of 2020. More conference insights on
#GeneOnline#AsiaMicrobiomeConference#IntestinalFlorahttps://wp.me/pb0TAP-109Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.